Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Spain
- Germany
- Sweden
- Denmark
- France
- Portugal
- Finland
- Canada
- Belgium
- Netherlands
- Poland
- Australia
- Switzerland
- Austria
- Czech
- Hong Kong
- Singapore
- China
- Italy
- Japan
- Norway
- Croatia
- Romania
- Brazil
- Luxembourg
- Malta
- Mexico
- Morocco
- New Zealand
- Saudi Arabia
- Taiwan
- 23 more »
- « less
-
Program
-
Field
-
high content imaging, multimodality in vivo imaging, proteomics, spatial and single-cell transcriptomics. As part of King’s Health Partners, we have an excellent environment for basic-clinical
-
) the molecular mechanisms of how these components work together to govern dynamic regulation of specific cellular processes. Our innovative approach combines proteomics, biochemistry, and advanced imaging
-
subteam develops mass‑spectrometry‑based proteomics, glycoproteomics, and metabolomics methodologies for diverse applications in patient care. Metabolomics developments include, but are not limited
-
glycosylation disorders and translate our findings into improved therapies and diagnostic biomarkers. Using patient‑derived materials, we apply cutting‑edge metabolomics and (glyco)proteomics to dissect disease
-
experiments involving genetic and pharmacological interventions in cells, as well as functional assays. The candidate will also have the opportunity to perform animal experiments, proteomics, metabolomics, and
-
discovery and validation (e.g., microRNA, proteomics, diagnostics) Translational animal models of disease Excellent skills in scientific communication, project management, and leadership Ability to work
-
/proteomics analysis pipelines. This involves analysing sequencing (both transcriptomic and proteomic) data and creation and implementation of all the relevant computational tools. In addition, this position
-
uses cutting-edge techniques including single-cell and spatial transcriptomics, proteomics, super-resolution microscopy, in vivo tracking, mouse models, and human patient tissues and iPS-derived cells
-
that are important for defense against pathogens by using genomics, proteomics, and metabolomics approaches. We aim to elucidate the signaling networks involved in plant immunity by analyzing the expression patterns
-
. The successful candidate will lead the computational efforts of developing and applying methods for applying proteomics and genetics data collected in situ for integrative structure modeling. Critical aspects